1. YoultenL.Lymphatics and lymph circulation. London: Pergamon Press1960:470–510.
2. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis.;Hagiwara A;Anticancer Res,1987
3. Enhanced chemotherapeutic efficacy on carcinomatous peritonitis using a new dosage form in animal experiments.;Hagiwara A;Anticancer Res,1987
4. Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form.;Hagiwara A;Anticancer Res,1986
5. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials